SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Bristol-Meyers Squibb

147

Bristol-Myers Squibb

BMY

Looking for leads, investment insights, or competitive intelligence?

CEO

Giovanni Caforio

CEO Title

Chief Executive Officer & Director

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New York, NY

Years on Fortune 500 List

23

Employees

25,000

Profile provided by S&P Global.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$19,42717.3%
Profits ($M)$4,457.0184.8%
Assets ($M)$33,707
Total Stockholder Equity ($M)$16,177
Market Value — as of March 31, 2017 ($M)$89,591
Profit Ratios
Profit as % of Revenues22.9%
Profits as % of Assets13.2%
Profits as % of Stockholder Equity27.6%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)2.65
EPS % Change (from 2015)184.9%
EPS % Change (5 year annual rate)4.2%
EPS % Change (10 year annual rate)12.6%
Total Return
Total Return to Investors (2016)-13.0%
Total Return to Investors (5 year, annualized)14.0%
Total Return to Investors (10 year, annualized)12.7%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Bristol-Myers Squibb

Supreme Court Ruling Could Save J&J Millions in Talc Cancer Lawsuits

The ruling led a St. Louis judge at J&J's urging to declare a mistrial in the latest talc case.

Read More →
The U.S. Supreme Court Has Been Incredibly Pro-Business This Term

Here are six rulings from 19 cases in which the U.S. Chamber of Commerce participated.

Read More →
3 Key Takeaways from the World's Biggest Cancer Conference

Promising cancer drugs took center stage at ASCO 2017, which wraps up Tuesday.

Read More →
Why Merck's Keytruda Just Became a Lung Cancer Game Changer

A new FDA approval gives Merck a huge advantage over its rivals.

Read More →
Trump's Nominee to Lead the FDA Got Paid Millions by the Health Care Industry

He'll have to recuse himself from decisions involving more than 20 companies.

Read More →